BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
78 hedge funds and large institutions have $148M invested in Bellicum Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
73% less call options, than puts
Call options by funds: $204K | Put options by funds: $753K
Holders
78
Holding in Top 10
–
Calls
$204K
Puts
$753K
Top Buyers
| 1 | +$5.77M | |
| 2 | +$2.67M | |
| 3 | +$1.93M | |
| 4 |
QF
QVT Financial
New York
|
+$1.56M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$720K |
Top Sellers
| 1 | -$8.54M | |
| 2 | -$6.18M | |
| 3 | -$5.37M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.37M |